Nature CommunicationsGlucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 DiabetesKuang-Ming LiaoJheng-Yan WuChih-Cheng Lai2026-08-22Full textDOI https://doi.org/10.1038/s41467-026-77068-0